SMARCC1 and cardiac hypertrophy: In mice with cardiac-specific Baf155 knockout treated with Ang II, the Ang II-induced heart dysfunction, cardiac hypertrophy, and fibrosis were significantly reduced, while the overexpression of Baf155 showed mild cardiac hypertrophy and aggravated vascular thickening and fibrosis induced by Ang II [123].